Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Digestive System Neoplasms × Docetaxel × Gastrointestinal × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 125 Esophageal Neoplasms 66 Pancreatic Neoplasms 37 Esophageal Squamous Cell Carcinoma 23 Adenocarcinoma Of Esophagus 23 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 16 Neoplasms 13 Colorectal Neoplasms 12 Neoplasm Metastasis 11 Prostatic Neoplasms 9 Squamous Cell Carcinoma of Head and Neck 8 Ovarian Neoplasms 8 Melanoma 8 Lung Neoplasms 7 Biliary Tract Neoplasms 7 Adenocarcinoma 7 Sarcoma 6 Colonic Neoplasms 6 Urinary Bladder Neoplasms 5 Small Cell Lung Carcinoma 5 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Gallbladder Neoplasms 5 Carcinoma, Renal Cell 5 Carcinoma, Hepatocellular 5 Head and Neck Neoplasms 4 Gastrointestinal Neoplasms 4 Esthesioneuroblastoma, Olfactory 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3

Interventions

Irinotecan 10 Fluorouracil 10 Leucovorin 9 Bevacizumab 9 Gemcitabine 7 Capecitabine 7 Paclitaxel 6 Oxaliplatin 6 130-nm albumin-bound paclitaxel 6 Cisplatin 5 Albumin-Bound Paclitaxel 5 napabucasin 4 Sorafenib 4 Drug Therapy 4 apatinib 3 Radiotherapy 3 Ocoxin 3 Imatinib Mesylate 3 Folfox protocol 3 Everolimus 3 Cetuximab 3 tislelizumab 2 spartalizumab 2 pembrolizumab 2 palbociclib 2 entinostat 2 encorafenib 2 camrelizumab 2 anlotinib 2 Sunitinib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05262335 2023-11-28

ALTER-G-001

Ruijin Hospital

Phase 2 Unknown

Gastrointestinal

Digestive System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡